Eleni Bilianou
Piraeus, ESYE31 18536, Greece
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Prevalence of Diabetes and Its Association with Atherosclerotic Cardiovascular Disease Risk in Patients with Familial Hypercholesterolemia: An Analysis from the Hellenic Familial Hypercholesterolemia Registry (HELLAS-FH).
Journal: Pharmaceuticals (Basel, Switzerland)
Published: November 07, 2022
Prevalence of Non-coronary Heart Disease in Patients with Familial Hypercholesterolemia: An Analysis from the HELLAS-FH.
Journal: Current pharmaceutical design
Published: September 15, 2020
Achieving low-density lipoprotein cholesterol targets as assessed by different methods in patients with familial hypercholesterolemia: an analysis from the HELLAS-FH registry.
Journal: Lipids in health and disease
Published: October 21, 2019
An insight into familial hypercholesterolemia in Greece: rationale and design of the Hellenic Familial Hypercholesterolemia Registry (HELLAS-FH).
Journal: Hormones (Athens, Greece)
Published: July 25, 2017
An insight into familial hypercholesterolemia in Greece: rationale and design of the Hellenic Familial Hypercholesterolemia Registry (HELLAS-FH).
Journal: Hormones (Athens, Greece)
Published: July 25, 2017
L-Carnitine/Simvastatin Reduces Lipoprotein (a) Levels Compared with Simvastatin Monotherapy: A Randomized Double-Blind Placebo-Controlled Study.
Journal: Lipids
Published: August 22, 2016
Expert consensus on the rational clinical use of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors.
Journal: Hormones (Athens, Greece)
Published: December 04, 2015
Long-term impact of multifactorial treatment on new-onset diabetes and related cardiovascular events in metabolic syndrome: a post hoc ATTEMPT analysis.
Journal: Angiology
Published: October 19, 2011
Showing 1-8 of 8
Last Updated: 09/26/2026